Medtronic Plc - Company Profile
Powered by 
All the sales intelligence you need on Medtronic Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Medtronic Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Medtronic Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Medtronic plc (Medtronic) is a medical technology company that designs, develops, manufactures, and markets medical devices and solutions. The company's major activities include research, design, manufacturing, and sales of biomedical engineering products. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous, renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose, and throat. Medtronic also provides biologic solutions for the orthopedic and dental markets. The company offers its products to hospitals, third-party healthcare providers, clinics, institutions including governmental healthcare programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.
Headquarters
Ireland
Address
Building 2, Parkmore Business Park West, Dublin, H914K49
Website
www.medtronic.com
Telephone
353 1 4381700
No of Employees
95,000
Industry
Medical Equipment
Ticker Symbol & Exchange
MDT (NYSE)
Revenue (2025)
$36.4B
8.4%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
2.9%
(2025 vs 2024)
Market Cap*
$116.1B
Net Profit Margin (2025)
XYZ
-5.0%
(2025 vs 2024)
* As of and is in US$
Medtronic Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Advanced Surgical Technology: | Accu-Temp |
| Electrosurgical Hardware | ACT Plus |
| Electrosurgical Instruments | Atlantis |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Regulatory Approval | In September, the company secured clearance from the U.S. Food and Drug Administration for the LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery (RAS) system. |
| 2026 | Contracts/Agreements | In September, the company invested US$700 million in Cornerstone Robotics and up to US$80 million in Pi-Cardia. |
| 2026 | Contracts/Agreements | In September, the company, Sailion, Sheffield Pharmaceuticals and ARBURG signed agreements with The University of New Haven to expand industry collaboration through its Elevation Center. |
Competitor Comparison
| Key Parameters | Medtronic Plc | Abbott Laboratories | Siemens Healthineers AG | Stryker Corp | Becton Dickinson and Co |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | Germany | United States of America | United States of America |
| City | Dublin | Abbott Park | Forchheim | Portage | Franklin Lakes |
| State/Province | - | Illinois | Bayern | Michigan | New Jersey |
| No. of Employees | 95,000 | 115,000 | 74,300 | 56,000 | 72,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Geoffrey S. Martha | Chairman; Chief Executive Officer | Executive Board | 2011 | 56 |
| Thierry Pieton | Chief Financial Officer; Executive Vice President | Senior Management | 2025 | 56 |
| Denise L. Blomquist | Chief Accounting Officer; Global Controller; Vice President | Senior Management | 2025 | - |
| Laura Mauri, M.D. | Chief Medical Officer; Chief Scientific Officer; Senior Vice President | Senior Management | 2022 | - |
| Matt Walter | Senior Vice President - Human Resources, IT and Global Communications & Corporate Marketing | Senior Management | 2023 | 47 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer